Gentak
NDC 50090-4770
Product Information
Gentak is a ANDA-approved product labeled by A-s Medication Solutions. This medication is used to treat bacterial infections (such as blepharitis, conjunctivitis) of the eye and the skin around the eyes (such as eyelids). It is supplied as a product. This product entry covers the primary NDC 50090-4770 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 50090-4770?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- GENTAMICIN SULFATE (UNII: 8X7386QRLV)
- GENTAMICIN (UNII: T6Z9V48IKG) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- PETROLATUM (UNII: 4T6H12BN9U)
- MINERAL OIL (UNII: T5L8T28FGP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 310466 - gentamicin sulfate 0.3 % (3 MG/GM) Ophthalmic Ointment
- RxCUI: 310466 - gentamicin 0.003 MG/MG Ophthalmic Ointment
- RxCUI: 310466 - gentamicin (as gentamicin sulfate) 0.3 % Ophthalmic Ointment
- RxCUI: 545236 - GENTAK 0.3 % (3 MG/GM) Ophthalmic Ointment
- RxCUI: 545236 - gentamicin 0.003 MG/MG Ophthalmic Ointment [Gentak]
* Please review the full disclaimer at the bottom of this page.
Patient Education
Gentamicin Ophthalmic
Ophthalmic gentamicin is used to treat certain eye infections. Gentamicin is in a class of medications called antibiotics. It works by killing the bacteria that cause infection.
[Learn More]
* Please review the full disclaimer at the bottom of this page.